New York, January 16, – IndexIQ, a New York Life Investments Company, today announced that Chris Hempstead has joined the firm as Director of Institutional Business Development to lead institutional ETF sales.
“Institutional investors are increasingly seeking innovative and diversified liquid alternative strategies at a lower cost than traditional investment vehicles,” said Jon Zimmerman, IndexIQ’s Chief Operating Officer. “Our growing suite of liquid alternative ETFs helps meet that need, and we are thrilled to welcome Chris, a preeminent thought leader and industry expert, to steward our continued institutional business development.”
A recent study commissioned by IndexIQ and Greenwich Associates projected that institutional investments in liquid alternative ETFs will more than double in the next 12 months, with nearly 20% of institutions who do not currently invest in liquid alternative ETFs planning to consider using them in 2020. Enhanced liquidity, heightened transparency and improved diversification were identified as the main benefits of liquid alternatives ETFs, with use-cases spanning transition management, fund of funds replacement, and core allocations.
“Our research with Greenwich underscores that, with liquid alternative ETFs on the upswing, now is the time for institutions to reevaluate their alternatives exposure,” added Hempstead. “IndexIQ is and has long been a pioneer in bringing-to-market innovative liquid alternative ETFs, and I am delighted to join the firm to further expand our growing institutional footprint.”
Hempstead joins IndexIQ after leading ETF sales at Deutsche Bank Securities, and serving as Head of ETF Sales at KCG Holdings. He has also held senior ETF roles at WallachBeth Capital, Cowen and Company, Van der Mooen, and Susquehanna International Group.
IndexIQ, a New York Life Investments company, is a provider of exchange-traded funds (ETFs), with a decade of offering highly differentiated and innovative solutions to retail and institutional investors. With $3.8 billion in assets under management as of December 31, 2019, IndexIQ leverages the asset management capabilities of New York Life Investments’ multi-boutique platform into its suite of offerings which include: fixed income, equities, alternatives and specialty asset classes.
All investments are subject to risk and will fluctuate in value.
Consider the Funds' investment objectives, risks, charges and expenses carefully before investing. The prospectus and the statement of additional information include this and other relevant information about the Funds and are available by visiting IQetfs.com or calling (888) 474-7725. Read the prospectus carefully before investing.
IndexIQ® is an indirect wholly owned subsidiary of New York Life Investment Management Holdings LLC and serves as the advisor to the IndexIQ ETFs. ALPS Distributors, Inc. (ALPS) is the principal underwriter of the ETFs, and NYLIFE Distributors LLC is a distributor of the ETFs. NYLIFE Distributors LLC is located at 30 Hudson Street, Jersey City, NJ 07302. ALPS Distributors, Inc. is not affiliated with NYLIFE Distributors LLC. “New York Life Investments” is both a service mark, and the common trade name, of the investment advisors affiliated with New York Life Insurance Company.
For additional information about IndexIQ, please contact:
Netanel Spero | New York Life Investments | (212) 576-3814 | Netanel_D_Spero@newyorklife.com
Chris Sullivan/Julia Stoll | MacMillan Communications | (212) 473-4442 | firstname.lastname@example.org